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Abstract. Human heterophile antibodies (HHA) that are present in normal human sera (NHS) play an im-
portant role in hyperacute xenograft rejection. The aim of this study was to analyze the occurrence, mode of ac-
tion and molecular specificity of HHA in NHS that are directed against xenogeneic Iymphocytes (isolated 
from mouse, rat, guinea pig, rabbit, cattle and pig) and isolated rat pancreatic islets. All sera contained variable 
amounts of HHA that killed the target cells via the classical complement pathway. The cytotoxic activity of 
these HHA was specifically inhibited by certain carbohydrates (a-D-melibiose, ß-Iactose, ß-gentiobiose, ß-cel-
lobiose, D-mannose, N-acetyl-ß-D-mannosamine and a-D-rhamnose) and by rat IgM. By means of affinity 
chromatography with immobilized inhibitors we obtained an antibody preparation of mainly IgG type from 
NHS (up to 3.5 mg/IO ml serum) that reacted strongly with rat lymphocytes and isolated rat pancreatic islets. 
Though thus far residual xenospecific antibody activity has remained in the sera even after multiple affinity 
chromatography, these data suggest that specific elimination of HHA is feasible and that it may be thus possi-
ble to overcome a major obstacle to xenotransplantation. 
Introduction 
Heterophile antibodies are antibodies that react 
with antigens with which the producing organism has 
not been immunized. That human heterophile anti-
bodies (HHA) occur in normal human sera (NHS) 
has been known at least since Ehrlich and Morgen-
roth discovered the ABO isohemagglutinins [I]. 
Much attention has been paid to HHA that appear 
under various pathological conditions, such as infec-
tious mononucleosis [2], serum sickness [3, 4], Kawa-
saki's disease [5], various malignancies [6], renal allo-
transplantation [6] and many others. 
One field in which heterophile antibodies present 
in normal sera play an important role is xenotrans-
plantation among more distantly related species, 
where grafts are usually rejected in a hyperacute fash-
ion. Most authors assurne that HHA in NHS trigger 
hyperacute xenograft rejection [7-13], while a few 
other authors [14] hold that direct antibody-independ-
ent activation of the alternate pathway of comple-
ment on the surface of xenogeneic target cells plays 
the main role in serum-mediated xenocytotoxicity. 
Attempts to avoid hyperacute xenograft rejection by 
means of plasmapheresis yielded only meager results 
[13, 15, 16], other attempts none. Thus far there ap-
pears to have been no really thorough analysis of the 
occurrence, cytotoxic mechanism and molecular spe-
cificity of xenocytotoxic HHA in NHS. For instance, 
in spite of the increasing interest in xenotransplanta-
tion of isolated pancreatic islets, there are no data 
available on the role of heterophile antibodies in hy-
peracute xenograft rejection. This obvious lack led us 
to perform the study reported in this paper. 
Material and Methods 
Stock Solutions 
The following stock solutions were used: 0.1 MEDTA (ethylene 
diamine tetraacetic acid), 0.1 M EGTA (ethylene glycol-bis-(ß-ami-
noethyl ether)-N,N,N,'N'-tetraacetic acid), 0.2 M CaCI2, 0.2 M 
MgCI2, 300 mM a-melibiose, ß-lactose, ß-gentiobiose, ß-cellobiose, 
D-mannose, N-acetyl-ß-D-mannosamine, a-rhamnose, D-glucose, 
saccharose, 10 mM dextran 10,000. 
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Table I. Mechanism of xenocytotoxicity of NHS 
Mean % dead cells 
(range) 
Treatment of serum 
medium 
(no serum) 
10 
(5-15) 
serum 
98 
(96-100) 
56"C 
30min 
10 
(5-15) 
50"C 
15min 
98 
(96-100) 
Laus/Ulrichs/Müller-Ruchholtz 
0.01 M EGTA 
0.05 M Mg 
10 
(5-15) 
0.01 M EGTA 
0.01 M Ca 
98 
(96-100) 
Identical results were obtained with 15 individual NHS, which were tested with 4 different Iymphocyte preparations each of 6 different 
target species. 
Serum Sampies 
Blood sampies from normal adult donors were allowed to c10t 
for 3 h at room temperature. The sera were used immediately or af-
ter freezing at -80"C for 3 months or less. 
Single Cell Preparations 
Lymphocytes were obtained from heparinized peripheral blood 
from pig, cattle and rabbit by using Ficoll-Hypaque gradient cen-
trifugation. They were washed (3 x) and suspended at a concentra-
tion of 2 x 106 cells/ml in RPMI 1640 medium. Lymph node cell sus-
pensions were prepared from guinea pig, rat and mouse by passing 
the excised nodes through a nylon net. Cells were washed and su-
spended in RPMI as above. 
Rat Pancreatic Islets 
Islets were isolated and purified by collagen ase digestion, Ficoll 
density gradient centrifugation and handpicking under a dissecting 
microscope using the green filter light technique [17]. 
Lymphocytotoxicity Test (LCT) 
The method of Terasaki and McClelland [18] was used in two 
modified versions: (I) A 1-111 cell suspension was incubated with 
5 111 fresh serum in a twofold dilution series for 2 h in microtest 
plates. Then 3.3 111 eosin and 6.6 111 10% formalin were added per 
weil. The percentage of dead cells was determined by means of 
phase contrast microscopy. Titers give the dilutions at which ap-
proximately 50% of the cells were killed. (2) The same procedure 
was followed, except that heat-inactivated human serum was used 
and after 1 h of incubation 5 111 of fresh normal rat serum was 
added as complement source. 
Immunojluorescence Assays 
Single cell suspensions were stained with a standard method on 
microtest plates. Intact rat pancreatic islets were stained according 
to the method of Ulrichs and Müller-Ruchholtz [19]. Briefly, about 
150 islets were suspended in 100 111 of serum for 30 min at 24"C in 
siliconized gl ass tubes. After washing 100111 anti-human Ig, FITC 
was added and incubation was performed at 4"C for 30 min in the 
dark. About 20 islets in 10 111 veronal buffer were transferred with a 
Pasteur pipette onto standard microscopic glass slides. A cover 
slide was placed on top. Thus, the islets remained undamaged and 
their genuine three-dimensional infrastructure appeared nearly 
two-dimensional, facilitating vertical screening. Each of the ten 
glass slides in one experiment was thoroughly screened for fluores-
cent islet cells with an inverted light fluorescence microscope. 
Affinity Chromatography Methods 
Cellobiose, gentiobiose, lactose and melibiose were each cou-
pled to 6 ml epoxy-activated Sepharose 6B in 10 mM NaOH at a 
concentration of 40 mg/mI. Mannose, rhamnose, and N-acetyl-
mannosamine were each coupled to 6 ml epoxy-activated Sepha-
rose 6B in 10 mM NaOH at a concentration of 20 mg/mi under 
normal conditions [20]. 50 mg rat IgM obtained through affinity 
chromatography on protamine Sepharose, followed by Sephacryl 
S300 gel filtration [21], were coupled to 7 ml CNBr-activated Se-
pharose 4B in carbonate buffer, pH 8.3, under normal conditions 
[20]. Gels were packed into chromatography columns. 10 ml serum 
was passed through the columns with a flow rate of 15 ml/h. They 
were washed until UV monitoring at 280 nm detected no desorbing 
protein. The fall-through fraction was collected and readjusted to 
the original volume with ultrafiltration. Bound material was eluted 
with citrate buffer, pH 2.5, and collected in 0.6M carbonate buffer, 
pH 9.6. It was dialyzed against PBS (3 x) for 24 h. Eluates were 
characterized by using a double immunodiffusion technique (anti-
sera: rabbit anti-human IgM, rabbit anti-human IgG, goat anti-hu-
man agammaglobulinemic serum components). The protein con-
tent of antibody preparations was roughly calculated by UV 
photometry at 280 nm. 
Results 
Mechanism of Xenolymphocytotoxicity of NHS 
In a first set of studies we examined the cytotoxi-
city of 30 NHS toward lymphocytes of mouse, rat, 
guinea pig, rabbit, pig and cow by LCT 1. The cyto-
toxicity showed a random distribution with lack of 
species preference. No dependence on, e.g., target 
species or the ABO group of the serum donor was 
seen. 15 of these sera, which, undiluted, killed nearly 
100% target cells from all 6 target species, were 
chosen for analysis of the mode of xenocytotoxic ac-
tion. Table I shows that when the serum is treated in 
ways that should still allow activation of the alternate 
complement pathway (e.g., chelation of Ca with 
EGT A in the presence of a high Mg concentration) 
cytotoxicity is completely abolished. In contrast, 
Xenocytotoxic Heterophile Antibodies 
heating (50oe, 15 min) wh ich should preferentially in-
activate the alternate pathway did not result in a loss 
of cytotoxieity. Only when classical complement acti-
vation was allowed, was cytotoxieity seen. 
Role of the Complement Source 
To determine wh ether the established LeT with 
heated (56 oe, 30 min) sera and xenogeneic comple-
ment source is useful for analyzing of HHA we pro-
ceeded as follows: the cytotoxieity of 18 sera to rat 
and pig lymphocytes was examined in parallel tests 
without and with rat normal serum as complement 
source (LeT 1 and LeT 2, see above). While the re-
sults of both LeT were comparable when the target 
was pig lymphocytes, LeT 2 always showed lower ti-
ters with the target rat lymphocytes than LeT 1 
(table 11). Other experiments clearly showed that 
LeT 2 always resulted in lower titers when comple-
ment source and target cells were from the same spe-
eies (data not shown). 
Xenoreactivity of HHA in NHS with Rat Pancreatic 
Islets 
Table III shows the reactivity of HHA with intact 
rat pancreatic islets, as detected by means of an im-
munofluorescence technique. All sera tested con-
tained HHA that reacted with one substructure or the 
other of the islets. As table III shows, HHA reacted 
mainly with connective tissue and vascular endotheli-
um. 7/10 NHS contained HHA that were directed 
against the endocrine cells of rat pancreatic islets. In-
hibition studies with carbohydrates and affinity 
chromatography with immobilized inhibitors yielded 
similar results as were obtained with lymphocytes (see 
beiow). In addition, islets that were preincubated with 
NHS produced significantly less insulin in in vitro 
cultures than untreated islets (data not shown). 
Molecular Specijicity of HHA 
IQ order to investigate the molecular speeifieity of 
HHA in NHS we performed the following inhibition 
assays: solutions of inhibitors were added to the test 
sera at room temperature 1 h before further testing. 
One respresentative example out of four inhibition 
studies is shown in table IV. The results can be sum-
marized as follows: dextran 10,000, glucose and sac-
charose do not have any effect on the original titers. 
The other carbohydrates showed varying inhibitory 
activity, dependent on the concentration and the tar-
get speeies. This was not due to anticomplementary 
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Table 11. Cytotoxic titers of 18 NHS for xenogeneic Iympho-
cytes without (LCT1) and with (LCT2) rat normal serum as com-
plement source 
Serum No. 
123 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 
Rat lymphocytes 
LCT1 108 2 16 8 8 4 2 8 0 2 8 8 8 8 0 
LCT2 000 2 I 0 0 0 0 0 0 2 0 0 0 
Pig lymphocytes 
LCTI I 016 8 16 8 4 8 2 4 0 8 16 16 16 8 4 0 
LCT2 208 432 4 2 8 2 4 0 8 8 16 16 8 2 0 
activity of the carbohydrates as was assured by using 
sera containing the carbohydrates as complement 
source for a cytotoxic rabbit anti-rat lymphocyte 
serum. No anticomplementary activity was seen. In 
the 4 sera tested, melibiose, the best inhibitor, showed 
inhibitory activity at a concentration of 1.5 mM in 
4/24 cases, at a concentration of 15 mM in 12/24 
cases and at a concentration of 150 mM in 16/24 
cases. The maximum titer reduction was 5 titer steps. 
The individual sera yielded different results. The inei-
dence of inhibition ranged from 19/144 cases up to 
55/144 cases. Inhibition varied, depending on target 
speeies: cytotoxieity toward mouse lymphocytes was 
inhibited in 2/96 cases, toward cattle and pig lympho-
cytes in 23/96 cases, toward rabbit lymphocytes in 
26/96 cases, and toward rat lymphocytes in 41/96 
cases. Rat IgM (1 mg/mI) completely inhibited cyto-
toxicity of NHS toward rat lymphocytes. 
Isolation of HHA by Means of Affinity 
Chromatography 
In this section we examined whether it is possible 
to eliminate xenospeeific HHA from NHS with im-
mobilized inhibitors. Approaches using Sepharose 
columns with only one immobilized sugar yielded 
small amounts of isolated antibodies and had no de-
tectable effect on the HHA content of NHS. The most 
successful approach was sequential adsorption to two 
Sepharose columns: all seven saccharides that pro-
duced positive results in inhibition studies were cou-
pled to one ofthem, rat IgM was coupled to the other. 
Table V summarizes the results: 1.0-3.5 mg anti-
204 Laus/Ulrichs/Müller-Ruchholtz 
Table III_ HHA in NHS that react with rat pancreatic islets shown by an immunofluorescence method using intact islets 
Serumno. 
2 4 
Endocrine cells 0 + ++ 
Vascular endothelium ++ +++ ++++ 
Connective tissue fibers ++ +++ ++++ 
5 
+ 
++ 
++ 
8 
o 
+++ 
+++ 
10 
o 
+ 
+ 
19 
+++ 
++++ 
++++ 
20 22 23 
+++ +++ ++ 
++++ ++++ ++ 
++++ ++++ ++ 
Fluorescence was graded by its intensity: + + + + = very strong; + + + = strong; + + = medium; + = weak; 0 = no detectab1e fluores-
cence. 
Table IV. Reduction of cytotoxicity of one NHS (No. 19) by various carbohydrates: results are expressed as reciprocal titers obtained 
with LCT! 
Sugar Lymphocyte source 
cattIe pig rabbit guineapig rat mouse 
8 16 16 32 16 8 
Me1ibiose 1.5mM 4 8 16 32 8 8 
15 2 4 8 8 4 8 
150 2 2 4 8 0 2 
Cellobiose I.5mM 8 16 16 32 8 8 
15 8 16 8 32 8 8 
150 4 8 8 16 8 
Lactose I.5mM 8 16 16 32 16 8 
15 8 16 8 32 4 8 
150 2 8 2 8 0 2 
Gentiobiose 1.5mM 8 16 16 32 16 8 
15 8 16 16 32 8 8 
150 4 8 8 8 2 8 
Mannose 1.5mM 8 16 16 32 16 8 
15 8 16 8 32 8 8 
150 4 16 8 8 2 8 
N-acetyl-mannosamine 1.5mM 8 16 16 32 16 8 
15 8 8 16 8 8 8 
150 8 2 8 8 2 8 
Rhamnose 1.5mM 8 16 16 32 16 8 
15 8 16 8 16 8 8 
150 8 16 8 16 8 
Dextran \0 8 16 16 32 16 8 
Glucose 150 8 16 16 32 16 8 
Saccharose 150 8 16 16 32 16 8 
Xenocytotoxic Heterophile Antibodies 
Table V. Isolation of HHA from NHS with immobilized inhibitors 
Serum No. 
19 
20 
21 
22 
Protein yield/ 
10mlserum 
3.512.0mg2 
3.0/1.5 mg 
3.0/1.0 mg 
2.5/1.0 mg 
Reactivity with 
anti-human Ig 
+++ 
+++ 
+++ 
+++ 
I aggs = agammaglobulinemic serum proteins. 
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anti-human IgG anti-human IgM anti-human aggs 1 
+++ + (+) 
+++ + (+) 
+++ + (+) 
+++ + (+) 
2 First result was obtained by affinity chromatography with the 7 carbohydrates that were efficient in inhibition studies attached to 
Sepharose. Second resuIt was obtained by affinity chromatography with rat IgM attached to Sepharose. 
bodies/ 1 0 ml NHS were isolated. In double immuno-
diffusion studies it was shown that this preparation 
yielded predominantly IgG. 
Reactivity of Isolated Antibodies 
All isolated antibodies reacted with rat lympho-
cytes and with isolated rat pancreatic islets at a con-
centration of 1 mg/mI, as shown by means of indirect 
immunofluorescence. 
Decrease in HHA Levels in NHS after Affinity 
Chromatography 
HHA levels for rat lymphocytes were studied by 
means of immunofluorescence in 4 sera before and af-
ter affinity chromatography. The highest serum dilu-
tion at which antibodies were detected on the cell sur-
face decreased in all 4 sera from 32 to 8. This indicates 
that so me but not all HHA that are specific for rat 
lymphocytes, were eliminated by affinity chromatog-
raphy with immobilized inhibitors. 
Discussion 
The occurrence of carbohydrate antigens in hetero-
phile systems was characterized succinctly by Kano 
and Milgrom [22]: 'One is tempted to say that protein 
antigens behave "with dignity" in following the evolu-
tionary pathway of development. The carbohydrates 
are those antigens that "play tricks" appearing in an 
unpredictable way.' 
It has often been presumed that HHA are carbohy-
drate-specific due to carbohydrate antigens shared 
between mammalian cells, microbes and plants [23, 
24]. We made the very compatible finding that xeno-
lymphocytotoxic HHA in NHS are inhibited by a va-
riety of carbohydrates. Antibodies in NHS directed 
against the carbohydrates we used have al ready been 
described in other contexts [25-28], but, to the best of 
our knowledge, inhibition of xenocytotoxic HHA in 
NHS by carbohydrates has not been shown before. 
Some heterophile antibodies in normal sera, such 
as in rabbit serum [29] and guinea pig serum [30], have 
been inhibited by various low molecular weight car-
bohydrates. Concerning NHS, such inhibition studies 
were successful when neuraminidase-treated human 
lymphocytes were used as target [31]. It can be ques-
tioned, however, whether the sugars with inhibitory 
activity are part of the cellular antigen to which they 
inhibit binding (which should be self-evident), since 
Milgrom's and Swieczynka's [32] recent discovery 
that 'natural' antibodies (e.g., HHA in NHS) may be 
multispecific, Le., one single antibody may bind two 
distinct epitopes the same time. Thus, inhibition 
could occur through steric hindrance. That it is, in 
principle, possible to isolate carbohydrate-specific 
antibodies out of NHS was first shown by Sela et al. 
[33]. Our attempts to eliminate HHA directed against 
xenogeneic cells from NHS with immobilized inhibi-
tors were partially successful. Affinity chromatogra-
phy eliminated some, but not all HHA that reacted 
with rat lymphocytes. These results may be explained 
as folIows: the heterogenous population of HHA con-
sists partly of carbohydrate-specific antibodies. Some 
of these have high affinity for low molecular weight 
carbohydrates and can be isolated by affinity chroma-
'tography. Others can be inhibited by high sugar con-
centration (Le., 150 mM), but their affinity is too low 
for successful affinity chromatography. This assump-
tion is supported by the unusual finding that the affin-
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ity-isolated HHA were mainly of IgG type, though 
HHA are generally believed to be mainly of IgM type. 
Thus it is possible that these HHA of IgM type were 
found in the fall-through fractions after affinity 
chromatography because of their low affinity for the· 
inhibitors. 
The particular HHA that we studied are cytotoxic 
toward xenogeneic lymphocytes via the classical com-
plement pathway. In other published attempts at an-
alyzing the xenocytotoxicity of NHS, other mechan-
isms have also been described. These include anti-
body-independent activation of the alternate comple-
ment pathway at the surface of xenogeneic target cells 
[14,34,35] and parallel action ofboth antibody-inde-
pendent activation of alternate complement pathway 
and antibody-dependent activation of the classical 
complement pathway [36]. These different results can 
be explained by the choice of target cells and by dif-
ferences in the experimental systems. 
The practical relevance of heterophile antibodies 
in normal sera in hyperacute xenograft rejection has 
often been shown: in experimental renal xenotrans-
plantation large immunoglobulin deposits ofhost ori-
gin were always found in hyperacutely rejected or-
gans [8-13, 16]. Thus, the elimination of xenospecific 
HHA from NHS remains a basic requirement for the 
successful abolition of hyperacute xenograft rejec-
tion. For this purpose, our studies present a method 
with a principle that may be useful. However, to be 
able to thoroughly eliminate all xenospecific HHA 
from NHS we need more knowledge of the structure 
of the pertinent antigens. 
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